Public health interventions are cost-effective methods to reduce heart disease. The present study investigated the impact of a low-cost priming technique on a public health campaign targeting cardiovascular risk. Participants were 415 individuals (66% female) ages 18 and older recruited through clinics and churches. The study consisted of three phases. In Phase I, participants completed a brief survey to assess knowledge of the cardiovascular health indicators. The survey served as the prime (intervention) for the study. At Phase II, participants were provided with access to a public health campaign consisting of an education brochure on cardiovascular health. Following the educational campaign, all participants completed a post-campaign survey in Phase III of the study. Participants who completed the surveys in both Phase I and III were placed in the intervention condition (26%) and those who only completed the Phase III survey were placed in the control condition (74%). Participants who were primed reported greater awareness of the public health campaign. Additionally, more intervention participants reported they had knowledge of their own and the normal ranges for cholesterol, glucose, and body mass index. For participants who were aware of the health promotion campaign, more participants in the primed group indicated they had knowledge of their own cholesterol and glucose levels and had made positive lifestyle changes as a result of the campaign. Results suggest the presence of a priming effect. Public health campaigns may benefit from the inclusion of a low-cost prime prior to intervention.

2010-09-01·Nursing & health sciences4区 · 医学

Research Article: Recruitment of hard-to-reach population subgroups via adaptations of the snowball sampling strategy

4区 · 医学

Article

作者: Hau-Chen Lee ; Rod Seung-Hwan Lim ; Georgia Robins Sadler ; Judith Fullerton

Nurse researchers and educators often engage in outreach to narrowly defined populations. This article offers examples of how variations on the snowball sampling recruitment strategy can be applied in the creation of culturally appropriate, community-based information dissemination efforts related to recruitment to health education programs and research studies. Examples from the primary author's program of research are provided to demonstrate how adaptations of snowball sampling can be used effectively in the recruitment of members of traditionally underserved or vulnerable populations. The adaptation of snowball sampling techniques, as described in this article, helped the authors to gain access to each of the more-vulnerable population groups of interest. The use of culturally sensitive recruitment strategies is both appropriate and effective in enlisting the involvement of members of vulnerable populations. Adaptations of snowball sampling strategies should be considered when recruiting participants for education programs or for research studies when the recruitment of a population-based sample is not essential.

2009-08-01·Midwifery3区 · 医学

Factors influencing health care-seeking behaviours among Mayan women in Guatemala

3区 · 医学

Article

作者: Christine Mundt ; Janine Schooley ; Pascale Wagner ; Judith Fullerton ; Mark O’Donnell

OBJECTIVE:

to identify and better understand factors that influence care-seeking behaviour for women's health among indigenous Mayan populations in the highlands of Guatemala.

DESIGN:

adaptation of qualitative anthropological methods involving observations, key informant interviews and focus group discussions (FGDs).

SETTING:

Project Concern International's Casa Materna, Huehuetenango, Guatemala.

PARTICIPANTS:

Interviews and FGDs were conducted among 21 clients (current or past) of the Casa Materna and traditional birth attendants; 17 female advocates/promoters of the Casa Materna and related services; and 12 male advocates, including spouses, non-government organisation staff and community health workers.

FINDINGS:

the following findings emerged from focus group data: Women's support groups (WSGs) provided an enabling environment in which women could form friendships, bond, discuss concerns about their reproductive health, and identify concrete ways of addressing them; Supportive friends, family members and advocates influenced women's decisions to seek health care at the Casa Materna; Women's decisions to seek care were often associated with their sense of self-worth and self-esteem, and women's self-esteem was enhanced by their participation in the WSGs; Women's decisions to seek care were influenced by the perception that women would be able to access culturally appropriate, safe and secure health care services at the Casa Materna; The learned behaviour of negotiation with key decision-makers and/or opinion leaders was an effective tool for convincing such individuals of the value of accessing facility-based care; The proven track record, high quality of services and cultural competence offered at the Casa Materna increased the confidence and level of trust of clients and their family members about the care that would be received; Couple-based education and health promotion were effective techniques for achieving behaviour and attitude change among both men and women.

KEY CONCLUSIONS:

the Casa Materna and its community outreach strategy serve an essential purpose in the provision of maternity care for the isolated and vulnerable families of the Guatemalan highlands, by bridging traditional and Western approaches to health care services. The Casa Materna service model plays a critical role in improving women's self-efficacy and ultimately strengthening the social fabric that characterises this high risk and vulnerable population.

IMPLICATIONS FOR PRACTICE:

the Casa Materna model provides a foundation upon which to bridge and strengthen the relationship between community advocates, traditional community-based health care providers, and the government-funded system of health care. The findings of this study should be incorporated into future research to determine the potential for bringing the model to scale.

项与 Global Communities 相关的新闻（医药）

2023-08-14

·Medical Design and Outsourcing

Pay drops for Medtronic CEO and the median employee; bonus plan changes

Medtronic disclosed total compensation for its top executives as well as its median worker while revealing changes to the way Medtronic Incentive Plan bonuses will be calculated. Medtronic (NYSE: MDT) paid Chair and CEO Geoff Martha $15.4 million in fiscal 2023, the world’s largest medical device company said in its annual disclosure of pay for top executives. That’s a 14% decrease from the year before, primarily due to Martha receiving nothing this year under the Medtronic Incentive Plan (MIP). Pay also dropped 14% to $67,073 for Medtronic’s median worker, which the company is required to identify for comparison to CEO pay. That CEO pay ratio increased from 215:1 to 230:1 in fiscal 2023 (ended April 28, 2023). Dublin, Ireland-based Medtronic used the same individual employee as its median worker as it did last year, saying there was “no change in our employee population or employee compensation arrangements since that median was identified that would affect the disclosure.” Medtronic’s disclosure did not include a precise count of its employees following this year’s voluntary early retirement program (VERP) and layoffs. Medtronic’s 2023 annual report said it had more than 95,000 global employees, the same figure it provided a year earlier. Medtronic did say, however, that it had 101,867 employees back in February 2022. Medtronic’s top-paid executives Martha was Medtronic’s top-paid executive, with a $1.35 million salary, $13.6 million in stock and option awards and $443,588 in other compensation. That other compensation included $296,569 worth of executive perks, such as a $40,000 business allowance and $256,569 for personal use of Medtronic aircraft. Medtronic EVP and CFO Karen Parkhill was Medtronic’s second-highest-paid executive at $6.1 million, down nearly 19% from the year before. Her fiscal 2023 compensation included a $911,059 salary and $5.1 million in stock and option awards. Medtronic EVP and Cardiovascular President Sean Salmon came next with nearly $5.4 million, including an $867,000 salary and $4.1 million in stock and option awards. Medtronic did not disclose his prior-year pay. Medtronic EVP and Global Regions President Rob ten Hoedt followed at $5 million, including a $907,368 salary, nearly $3.5 million in stock and option awards, and a $269,630 cash bonus for his 2021 promotion. Medtronic EVP and Medical Surgical Portfolio President Rob White also made around $5 million, including a $794,539 salary and $4.1 million in stock and option awards. Related: 5 growth areas where Medtronic’s CEO wants to invest more Changes to the Medtronic Incentive Plan (MIP) MIP pays a cash bonus based on certain “tough but fair financial performance expectations” such as revenue, profits, free cash flow, market share. The MIP could have paid Martha around $2 million this year, but he and his four top-paid executives received nothing because “financial performance was below our target expectations,” the company said in its filing. Medtronic’s fiscal 2023 revenue decreased 1% year-over-year to $31.2 billion, while annual profits (net income) decreased 25% to approximately $3.8 billion. Medtronic said it has changed the MIP for the current year so that missing the earnings per share target won’t disqualify senior executives from payouts. “Each element of the Medtronic Scorecard will be assessed independently,” the company said. “Further, the MIP will remove market share at the Medtronic Scorecard level. Therefore, the Medtronic Scorecard will be an equally weighted measurement of revenue growth, diluted EPS and free cash flow.” Related: Ahead of Medtronic RDN’s FDA review panel, analysts place their bets Medtronic’s annual meeting Medtronic has moved its annual meeting of shareholders — traditionally held in Dublin in December — to October. Investors will vote on Medtronic’s board of directors, executive compensation practices and proposals from shareholders. Shareholders who want to nominate directors or submit other proposals have until Aug. 30. More on executive pay: Owens & Minor executive pay dropped ahead of realignment ZimVie discloses executive pay and severance for first C-suite exit Baxter CEO pay dropped amid Hillrom challenges Boston Scientific discloses executive pay, reports employment and diversity gains Ashley McEvoy joins J&J’s top-paid executives Stryker discloses $40M in pay for CEO Kevin Lobo and top execs GE HealthCare’s CEO earned more than GE’s CEO before spinoff Baxter caps cash severance payouts for executives Masimo shareholders vote ‘no’ on executive pay Henry Schein investors push back on executive pay

财报高管变更并购

2021-05-28

·Healthcare IT News

Roundup: AWS to launch data centres in UAE, Ibex obtains CE Mark for AI-powered breast cancer detection and more briefs

AWS TO OPEN DATA CENTERS IN UAE Amazon Web Services (AWS), an Amazon.com company, plans to open an infrastructure region in the United Arab Emirates (UAE) in the first half of 2022. The new AWS Middle East (UAE) Region will consist of three Availability Zones and will become AWS's second region in the Middle East with the existing AWS Region in Bahrain. The initiative aims to give customers more choice and flexibility to leverage technologies from the new cloud infrastructure, allowing customers to run workloads and store data locally while serving end-users. The expansion is part of AWS's aims to build on its current 80 Availability Zones globally across 25 geographic regions. “We are excited to build on the great momentum of cloud adoption in the Middle East by providing more choice for customers in the UAE to run applications and store data locally,” said Peter DeSantis, senior vice president of Global Infrastructure, AWS. “The new AWS Region supports the UAE’s focus on promoting technology innovation that has made it a thriving global hub for entrepreneurs, e-governments, and multi-national businesses. With the new region, organisations of all sizes will be able to innovate faster and serve end-users with even lower latency across the region.” IBEX OBTAINS CE MARK FOR AI-POWERED BREAST CANCER DETECTION Israel-based AI-powered cancer diagnostics company Ibex Medical Analytics has obtained a CE Mark for its Galen Breast solution used for supporting pathologists in the detection of breast cancer. The CE Mark follows results from a blinded, multi-site clinical study at Institut Curie in France and Maccabi Healthcare Services in Israel. Galen Breast demonstrated high accuracy in detecting various types of breast cancer, including invasive and in-situ cancers, distinguishing between different types of invasive cancer and grading of DCIS lesions. The solution is now available as Ibex partners with laboratories, hospitals and health systems to implement artificial intelligence (AI) technology into the diagnostic workflow. Galen Breast has already been ordered by multiple labs, including a network-wide deployment at a leading pathology group in Europe. TELEPHONY PROVIDER DEPLOYED ACROSS LONDON AND MANCHESTER UK-based cloud telephony specialist X-on has completed two deployments of its Surgery Connect cloud-telephony system, extending take-up to a further 120 general practices in London and Greater Manchester. Eighty GP practices within North Central London Clinical Commissioning Group’s catchment, about 40 percent of all the catchment practices, have opted for the product to enhance their practice-patient communications, and in Stockport, Greater Manchester, all the area’s 36 practices have now moved to Surgery Connect. An additional estimated one million patients are now supported by X-on’s Surgery Connect product following the deployments, which have been completed during the pandemic. In total, an estimated 8.5 million patients are now served by 835 practices in England and Wales using Surgery Connect. INTERSYSTEMS AND ONCODESIGN PARTNER TO ACCELERATE DRUG DISCOVERY US-based healthcare data management company, InterSystems and France-based biopharmaceutical company, Oncodesign have announced their strategic partnership aimed at advancing research for new treatments in the field of oncology. As part of this partnership, Oncodesign has chosen to combine its proprietary platform for the identification and validation of new therapeutic targets, called OncoSNIPER, with InterSystems' unified health data management platform, known as InterSystems IRIS for Health. The InterSystems IRIS for Health data platform will be integrated into Oncodesign's recently established Artificial Intelligence (AI) Business Unit for the storage and management of preclinical and clinical data sources, which are involved in the drug discovery process. By analysing the data consolidated through InterSystems IRIS for Health, Oncodesign's AI BU aims to optimise the development of OncoSNIPER, through more accurate functioning of its algorithms. In addition, InterSystems will provide Oncodesign with the benefit of its international network of strategic academic partners generating health data in North America. ECONSULT HEALTH ACQUIRES Q DOCTOR UK-based digital triage provider eConsult has acquired video consultation and SMS platform Q doctor, combining online triage, video, telephony and SMS in one joined-up solution for GP surgeries and hospitals. The acquisition of Q doctor is the latest step in eConsult’s expansion, having secured a £7 million investment from Gresham House Ventures and Calculus Capital in October 2020 to enter into the secondary care market. eConsult allows patients to submit their symptoms or requests to their own GP electronically and offers NHS self-help information, signposting to services, and a symptom checker. eConsult is used by 3,330 GP surgeries and has been used to complete over 13 million online consultations. Its eTriage platform, purpose-built for emergency care is currently in use at nine hospitals including Worthing & St Richards in Western Sussex.

并购

100 项与 Global Communities 相关的药物交易

登录后查看更多信息

100 项与 Global Communities 相关的转化医学

登录后查看更多信息